Cubosomes for in vivo fluorescence lifetime imaging

Nanotechnology. 2017 Feb 3;28(5):055102. doi: 10.1088/1361-6528/28/5/055102. Epub 2016 Dec 29.

Abstract

Herein we provided the first proof of principle for in vivo fluorescence optical imaging application using monoolein-based cubosomes in a healthy mouse animal model. This formulation, administered at a non-cytotoxic concentration, was capable of providing both exogenous contrast for NIR fluorescence imaging with very high efficiency and chemospecific information upon lifetime analysis. Time-resolved measurements of fluorescence after the intravenous injection of cubosomes revealed that the dye rapidly accumulated mainly in the liver, while lifetimes profiles obtained in vivo allowed for discriminating between free dye or dye embedded within the cubosome nanostructure after injection.

MeSH terms

  • Animals
  • Carbocyanines / chemistry*
  • Carbocyanines / pharmacokinetics
  • Carbocyanines / pharmacology
  • Cell Survival / drug effects
  • Drug Compounding / methods
  • Erythrocytes / drug effects
  • Female
  • Fluorescent Dyes / chemistry*
  • Fluorescent Dyes / pharmacokinetics
  • Fluorescent Dyes / pharmacology
  • Glycerides / chemistry
  • Humans
  • Injections, Intravenous
  • Liposomes / chemical synthesis
  • Liposomes / pharmacokinetics*
  • Liver / drug effects
  • Liver / metabolism
  • Liver / ultrastructure
  • Mice
  • Mice, Inbred BALB C
  • NIH 3T3 Cells
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*
  • Optical Imaging / methods*
  • Particle Size
  • Spectroscopy, Near-Infrared / methods*
  • Time-Lapse Imaging

Substances

  • CY5.5 cyanine dye
  • Carbocyanines
  • Fluorescent Dyes
  • Glycerides
  • Liposomes
  • monoolein